Capricor Therapeutics Inc (STU:4LN2)
€ 7.99 +0.93 (+13.18%) Market Cap: 466.38 Mil Enterprise Value: 340.56 Mil PE Ratio: 0 PB Ratio: 2.21 GF Score: 34/100

Capricor Therapeutics Inc (STU:4LN2) Transcripts

  • 1